drugset / Trial / NCT00355407
Darbepoetin Alfa (Aranesp) Following Allogeneic Stem Cell Transplantation
Completed
31 enrolled
Dana-Farber Cancer Institute
Amgen · collabBrigham and Women's Hospital · collab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to find out if Darbepoetin alfa is effective in treating low red blood cell levels after allogeneic stem cell transplant. Darbepoetin alfa has been shown to help raise red blood cell levels without blood transfusions.
Timeline
- Start
- 2006-06
- Primary completion
- 2007-08
- Completion
- 2007-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Darbepoetin alfa | Protein / enzyme biologic | — | Subcutaneous |